
Mana.bio
AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
About
Mana.bio is an AI-based drug delivery startup focused on gene therapy, including DNA and RNA-based therapeutics and vaccines. Their technology integrates machine learning and nanotechnology to identify lipid nanoparticle drug delivery systems. They offer ChatLNP, an AI agent named Mina, to help scientists explore literature, predict LNP properties, and optimize formulations.
Listed competitors
Also in this space
AI-driven digital twin of embryo development for cell-based therapies.
Shares Life Sciences, Therapeutics
Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
Shares Life Sciences, Therapeutics
AI-powered patient-centric drug simulations to accelerate and de-risk drug development.
Shares Life Sciences, Drug Discovery
Develops a platform for adaptive clinical trial design and closed-loop execution.
Shares Life Sciences, Drug Discovery
AI-driven platform for protein-level disease mapping and drug discovery.
Shares Life Sciences, Drug Discovery
Computational platform using LLMs trained on biological and chemical data for drug discovery.
Shares Life Sciences, Drug Discovery
Key facts
- Website
- mana.bio
- Headquarters
- Boston, United States
- Founded
- 2021
- Employees
- 20
- Total funding
- $20M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 10 Oct 2023 | Seed | $15M | NFX, LionBird, Base4 Capital, Technion, Another VC |
| 22 Oct 2022 | Seed | $5M | LionBird, NFX |
Tech stack
Detected on mana.bio, last scanned 6 Sept 2026. Run your own scan
- Observability
- Sentry
- CMS / Builders
- Wix
- Email provider
- Google Workspace
Mana.bio scores 30. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Mana.bio trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Mana.bio is 70 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Mana.bio raised?
Mana.bio has raised a total of $20M in funding. The most recent round on record is Seed.
How many employees does Mana.bio have?
Mana.bio has approximately 20 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Mana.bio


